{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-415555","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2026-10-06T20:06:55+00:00","discovered_at":"2026-10-06T20:08:02.422963+00:00","generated_at":"2026-10-12T16:20:57.187070+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Inovio adds Delaware exclusive-forum bylaw covering derivative and fiduciary-duty suits","bullets":["Board approved the Bylaws Amendment on October 6, 2026, effective immediately; CFO Peter Kies signed the report.","New Article 12 designates the Delaware Court of Chancery as exclusive forum for derivative actions and claims of breach of fiduciary duty by directors, officers or stockholders.","The U.S. federal district courts are named the exclusive forum for any complaint arising under the Securities Act of 1933.","Full text of the amendment is filed as Exhibit 3.1 to the Form 8-K; no financial terms or dollar amounts disclosed.","No change to the Company's certificate of incorporation, fiscal year, or share count was disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-415555","json":"https://secwatch.observer/filing/0001193125-26-415555.json","markdown":"https://secwatch.observer/filing/0001193125-26-415555.md","text":"https://secwatch.observer/filing/0001193125-26-415555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/0001193125-26-415555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526415555/d127604d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:20:57.187070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}